FDA Inspection 620167 — Community Blood Center Of Greater Kansas City

Community Blood Center Of Greater Kansas City — FEI 1972933

The FDA completed an inspection of Community Blood Center Of Greater Kansas City on October 30, 2009 in Kansas City, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 30, 2009
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, MO (United States)